Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • Fund battling AIDS, TB...

    Fund battling AIDS, TB and malaria seeks $14 billion to invigorate fight

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-01-12T09:15:48+05:30  |  Updated On 12 Jan 2019 9:15 AM IST
    Fund battling AIDS, TB and malaria seeks $14 billion to invigorate fight

    The Global Fund is a group of governments, civil society and private sector partners which invests around $4 billion a year to fight infectious diseases. It was launched in 2002 and has since helped slash the number of people dying from AIDS, TB and malaria by around a third.


    LONDON: At least $14 billion is needed to accelerate the fight against AIDS, tuberculosis and malaria and quell stubborn epidemics that still kill millions, the head of a global health fund said on Friday.


    Announcing a fundraising target for the next three-year cycle, Peter Sands, director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, said the money could help save 16 million lives, halving deaths from the three diseases.


    It would also be used to build stronger health systems in poor countries ill-equipped to handle existing outbreaks and unable to cope with potential new epidemics.


    “New threats mean there is no middle ground,” Sands said in a statement. “We need to ... protect and build on the gains we have made, or we will see those achievements eroded, infections and deaths resurge, and the prospect of ending the epidemics disappear.”





    The Global Fund is a group of governments, civil society and private sector partners which invests around $4 billion a year to fight infectious diseases. It was launched in 2002 and has since helped slash the number of people dying from AIDS, TB and malaria by around a third.



    Yet the epidemics are still far from beaten.


    In 2017, TB killed 1.6 million people, including 300,000 people with HIV, making it one of the top 10 causes of death worldwide. Malaria kills almost half a million people each year, most of them babies or young children in sub-Saharan Africa.


    In the AIDS pandemic, almost 37 million people worldwide are infected with the human immunodeficiency virus (HIV) and around 15 million of them do not get the antiretroviral drugs needed.


    Sands acknowledged in a telephone interview how hard it would be to encourage international donors to pledge funds towards such a high target. But he added that with the fund’s reach and ability to elicit engagement and investment by governments in nations affected by the epidemics, he was confident it would have a major impact.


    “If we step up the fight now, we will save millions of more lives,” he said.


    Also Read: India, Netherlands, Sweden collaborate for HIV/AIDS research
    AIDSantiretroviral drugsFund battlingHIVHIV AIDShuman immunodeficiency virusinfectious diseasesinvigorate fightLondonmalariaPeter Sandsquell stubbornTB
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok